|
CNNM4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.37427871702312E-14 |
| Normal-vs-Stage2 |
2.46269671322352E-11 |
| Normal-vs-Stage3 |
8.08353384229576E-12 |
| Normal-vs-Stage4 |
8.70503669148093E-12 |
| Stage1-vs-Stage2 |
3.070200E-01 |
| Stage1-vs-Stage3 |
4.573800E-01 |
| Stage1-vs-Stage4 |
3.291800E-01 |
| Stage2-vs-Stage3 |
6.952800E-01 |
| Stage2-vs-Stage4 |
8.944000E-01 |
| Stage3-vs-Stage4 |
7.884200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4432899320127E-15 |
| Normal-vs-AfricanAmerican |
1.84789999968515E-08 |
| Normal-vs-Asian |
3.89919999621569E-08 |
| Caucasian-vs-AfricanAmerican |
8.805600E-01 |
| Caucasian-vs-Asian |
4.444000E-01 |
| AfricanAmerican-vs-Asian |
4.767200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18283161043564E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
2.044600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6269208202857E-12 |
| Normal-vs-Age(41-60Yrs) |
1.96176408451265E-13 |
| Normal-vs-Age(61-80Yrs) |
1.22399868018874E-11 |
| Normal-vs-Age(81-100Yrs) |
5.119200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.629600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.007600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.495200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.314600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.765600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.298600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.012400E-01 |
| Classical-VS-Follicular |
9.215800E-02 |
| Classical-VS-Other |
3.726600E-01 |
| Classical-VS-Normal |
1.31859967389403E-10 |
| Tall-VS-Follicular |
4.260000E-01 |
| Tall-VS-Other |
4.484400E-01 |
| Tall-VS-Normal |
9.96190019364462E-10 |
| Follicular-VS-Other |
8.546800E-01 |
| Follicular-VS-Normal |
7.97517607509235E-12 |
| Other-VS-Normal |
5.810800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
7.18092252327551E-13 |
| N0-vs-N1 |
1.909810E-01 |
|
|
